Safety, Tolerability and Pharmacokinetics of MK-4334 in Participants With Alzheimer's Clinical Syndrome on a Stable Dose of Donepezil (MK-4334-005)

Conditions:   Alzheimer's Disease;   Mild Cognitive Impairment Interventions:   Drug: MK-4334;   Drug: Placebo to MK-4334;   Drug: Donepezil Sponsor:   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials